Historical record - last NADAC effective date: 8/17/2022
Product Information
QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.3606 per EA under NDC 43386071109. Its NADAC has been published 483 times since Nov 28, 2013.
FDA first approved this application on Mar 31, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12.5; 20 mg/1; mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
43386071109
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/17/2022
Active Ingredients
HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076374FDA Approved
3/31/2004
TE Code
AB
On Market Since
7/15/2011
Pharmacological Classes
Price Statistics
The NADAC for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 483 times since Nov 28, 2013, and over the history we have for it it has declined 39.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3606 per EA |
|---|---|
| All-time high | $0.6584 (Mar 16, 2016) |
| All-time low | $0.2712 (Oct 21, 2020) |
| Median price | $0.4917 |
| Average price | $0.4827 |
| Largest weekly change | -47.7% (Oct 21, 2020) |
| Weeks tracked | 483 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-16.8%
All
-39.9%
Last surveyed Feb 22, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Lupin Pharmaceuticals Inc., is $0.3606 per EA (NDC 43386071109), effective Feb 22, 2023.
How has the price of QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has declined 39.9%. It has been tracked across 483 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
Since Nov 28, 2013, the NADAC for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.2712 (Oct 21, 2020) to a high of $0.6584 (Mar 16, 2016), with a median of $0.4917 per EA.
Are there cheaper alternatives to QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 43386071109) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.